Tech Center 1600 • Art Units: 1655
This examiner grants 36% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19254270 | COMPOSITION AND METHOD FOR EXPEDITING DENTAL ANESTHESIA RECOVERY | Non-Final OA | David Drescher |
| 18253662 | USE OF CRASSOCEPHALUM RABENS EXTRACT IN THE PREVENTION AND/OR TREATMENT OF FATIGUE AND/OR DEPRESSION | Non-Final OA | ACADEMIA SINICA |
| 18097370 | CANNABIS AND MUSHROOM COMPOUNDS INFUSED CONSUMABLES | Final Rejection | TLCO HOLDINGS INC. |
| 17911241 | METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS | Non-Final OA | DST Pharma, Inc. |
| 18515601 | RHODIOLA CRENULATA COMPOSITIONS AND METHODS OF MAKING THE SAME | Non-Final OA | NutriScience Innovations LLC |
| 17910894 | COMPOSITION FOR PREVENTING OR TREATING CARDIOVASCULAR AND METABOLIC DISEASES COMPRISING ELAEOCARPUS PETIOLATUS | Final Rejection | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY |
| 18561157 | IN VITRO CULTURE EXTRACT OF ARISTOTELIA CHILENSIS (MAQUI) WITH ANTIOXIDANT, PROTECTIVE AND SKIN REPAIRING PROPERTIES | Non-Final OA | FUNDACION COPEC UNIVERSIDAD CATÓLICA |
| 18386113 | ADVANCED ORAL FILM FORMULATIONS | Non-Final OA | INTELGENX CORP. |
| 18482631 | FORMULATION FOR THE PREVENTION AND/OR TREATMENT OF COVID-19 | Non-Final OA | SERVIDENCE INC. |
| 18467740 | METHOD FOR IMPROVING BIOAVAILABILITY OF NAD+ DERIVATIVES | Non-Final OA | HOBOOMLIFE BIO-TECHNOLOGY (SHENZHEN) CO., LTD. |
| 18268146 | NUTRACEUTICAL COMPOUNDS USEFUL IN THE TREATMENT OF CORONAVIRUS DISEASE | Non-Final OA | THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE |
| 18253484 | Yeast B-Glucan Emulsion, Methods and Uses Thereof | Non-Final OA | AMYRIS BIO PRODUCTS PORTUGAL UNIPESSOAL LDA |
| 18263732 | METHOD FOR PROMOTING ANTIOXIDANT ACTIVITY OF PURPLE TEA LEAVES | Final Rejection | CLEANBEAUTY INC. |
| 18357149 | CAROTENOID PREPARATIONS, PREPARATION METHODS, AND APPLICATION THEREOF | Final Rejection | INNOBIO CORPORATION LIMITED |
| 17718624 | PRE-MOISTENED WIPES FOR USE IN TREATING ANAL RECTAL IRRITATIONS AND DISORDERS | Final Rejection | HALEON US HOLDINGS LLC |
| 18266396 | COMPOSITION COMPRISING SEA CUCUMBER GENITAL GLAND EXTRACT, COMPOUND DERIVED FROM SEA CUCUMBER OVARY EXTRACT, AND USE THEREOF | Non-Final OA | BENTHIC BIO INC. |
| 17296733 | Intact Pea Protein-Based Nutrient Composition | Final Rejection | Kate Farms, Inc. |
| 18150984 | METHOD FOR INCREASING MELATONIN IN SUBJECT AND REGULATING EXPRESSION OF TPH GENE, DDC GENE, AANAT GENE, AND ASMT GENE BY USING LONGAN FLOWER EXTRACT | Final Rejection | NUTRAREX BIOTECH CO., LTD. |
| 18067805 | COMPOSITION COMPRISING A COMPLEX COMPRISING A CURCUMINOID COMPOUND, AND STEVIOL GLYCOSIDES OR A LICORICE EXTRACT OR A FRACTION THEREOF, AND USES THEREOF | Final Rejection | BIOTEN CO., LTD |
| 17912106 | TRANQUILIZING COMPOSITION | Non-Final OA | NATURAL ENDOTECH CO., LTD. |
| 17925842 | COMPOSITIONS AND COMBINATIONS FOR SUBJECTS SUFFERING FROM ENDOMETRIOSIS | Final Rejection | GYNOV |
| 17913812 | COMPOSITION COMPRISING EGG YOLK AND BURNT CERAL POWDER FOR WOUND HEALING | Final Rejection | Sahebi Aps |
| 17912821 | PSILOCYBIN AND PSILOCIN CONTAINING COMPOSITIONS AND METHODS OF USING AND MAKING THE SAME | Non-Final OA | Orthogonal Thinker, Inc. |
| 17946578 | TGF-BETA INHIBITION, AGENTS AND COMPOSITION THEREFOR | Non-Final OA | GMP BIOTECHNOLOGY LIMITED |
| 17905390 | Antibacterial Antiviral Pharmaceutical Composition and Application Thereof | Non-Final OA | Yunnan Baiyao Group Company Limited |
| 17904485 | HERBAL PREPARATION FOR PREVENTION AND TREATMENT OF HELICOBACTER PYLORI INFECTION | Non-Final OA | HerbElixa DOO SREMSKA KAMENICA |
| 17697046 | ENDOCANNABINOID MIMETIC AND ANTI-INFLAMMATORY COMPOUND CONTAINING COMPOSITIONS, METHODS OF PREPARATION AND USES THEREOF | Non-Final OA | PHARMA COSMETIX RESEARCH, LLC |
| 17638067 | CARNOSIC ACID, CARNOSOL AND ROSMARINIC ACID ISOLATION METHOD | Non-Final OA | TUBITAK |
| 16564251 | EAR SPRAY DEVICE AND EAR PROTECTION COMPOSITION FOR PREVENTING WATER RELATED EAR CANAL DISORDERS | Non-Final OA | LiquidPro Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy